The University of Chicago Header Logo

Connection

Ravi Salgia to Sirolimus

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Sirolimus.
Ravi Salgia
Connection Strength
0.383
Sirolimus
  1. A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin. Clin Cancer Res. 2005 Mar 15; 11(6):2312-9.
    View in: PubMed
    Score: 0.236
  2. A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2018 08; 82(2):309-317.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.